January 1, 2011 Section 17b-274(d) is an update the Connecticut General Assembly by Public Act 09-5 regarding nonpreferred drugs in the classes included on the preferred drug lists shall be subject to prior authorization.Last accessed: December 8, 2011. Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Chapter 319v: Connecticut Pharmaceutical and Therapeutics Committee

January 1, 2011 Section 17b-274(d) is an update the Connecticut General Assembly by Public Act 09-5 regarding nonpreferred drugs in the classes included on the preferred drug lists shall be subject to prior authorization.Last accessed: December 8, 2011. Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.